Keyphrases
Positron Emission Tomography
100%
In Cancer
100%
First-in-human Study
100%
Poly(ADP-ribose) Polymerase
100%
Preclinical Assessment
100%
Olaparib
100%
Iniparib
100%
Polymerase
75%
Adenosine Diphosphate Ribose
75%
Polyadenosine
75%
Radiation Dosimetry
50%
Median Difference
50%
Treatment Group
25%
Tumor
25%
Liver Cancer
25%
Human Subjects
25%
Clinical Application
25%
Inhibitory Activity
25%
Mouse Organs
25%
Pancreas
25%
Spleen
25%
Institutional Review Board
25%
Spine
25%
Healthy Volunteers
25%
Area under the Receiver Operating Characteristic Curve
25%
Effective Dose
25%
Translational Studies
25%
Biodistribution Studies
25%
Wilcoxon Signed-rank Test
25%
Pancreatic Adenocarcinoma
25%
Fluorine-18
25%
Poly(adenosine diphosphate-ribose) Polymerase inhibitor
25%
Clinical Trial Evaluation
25%
Medicine and Dentistry
Malignant Neoplasm
100%
Positron Emission Tomography
100%
Fluorine-18
100%
Human Study
100%
Poly ADP Ribose Polymerase
100%
Olaparib
50%
Iniparib
50%
Dosimetry
25%
Neoplasm
12%
Liver Cancer
12%
Clinical Trial
12%
Wilcoxon Signed Ranks Test
12%
Human Subject
12%
Volunteer
12%
Biodistribution
12%
Mouse Study
12%
Pancreas Adenocarcinoma
12%
Treatment Group
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Human Study
100%
Fluorine 18
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Olaparib
50%
Iniparib
50%
Dosimetry
25%
Liver Cancer
12%
Neoplasm
12%
Clinical Trial
12%
Normal Human
12%
Biodistribution
12%
Pancreas Adenocarcinoma
12%
Homo sapiens
12%
Treatment Group
12%